1. An entirely new combination. An original analgesic, which is not a scheduled drug.
2. The combination is in complete compliance with a global trend of multimodal analgesia.
3. The option for adequate pain control (equivalent to morphine) achieved with low doses and with minimal complications and adverse effects.
The conditions for licensing-out selling of the product.
1. Documents to be transferred: